Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

J Appl Physiol (September 6, 2002). doi:10.1152/japplphysiol.00477.2002
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
93/6/2112    most recent
00477.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahlborg, G.
Right arrow Articles by Lindstrom, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahlborg, G.
Right arrow Articles by Lindstrom, J.

Articles in PresS, published online ahead of print September 6, 2002
J Appl Physiol, 10.1152/jap.00477.2002
Submitted on May 31, 2002
Accepted on August 29, 2002

Insulin sensitivity and big endothelin-1 conversion to endothelin-1 after ETA or ETB receptor blockade in humans

Gunvor Ahlborg1* and Jonas Lindstrom1

1 Department of Medical Laboratory Sciences and Techonology, Division of Clinical Physiology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: Gunvor.Ahlborg{at}labtek.ki.se.

Cardiovascular diseases are characterized by insulin resistance and elevated endothelin-1 (ET-1) levels. Further, ET-1 induces insulin resistance. To elucidate this mechanism six healthy subjects were studied during a hyperinsulinemic euglucemic clamp during infusion of (the ET-1 precursor) big ET-1 alone or after ETA or ETB receptor blockade. Insulin levels rose after big ET-1± the ETB antagonist BQ788 (p<0.05), but were unchanged after the ETA antagonist BQ123+big ET-1. M/I (infused glucose devided by insulin) fell after big ET-1± BQ788 (p<0.05). Insulin and M/I values were normalized by ETA blockade. Mean arterial blood pressure rose during big ET-1±BQ788 (p<0.001) but was unchanged after BQ123. Skeletal muscle, splanchnic and renal blood flow responses to big ET-1 were abolished by BQ123. ET-1 levels rose after big ET-1 (p<0.01) in a similar way after BQ123 or BQ788, despite higher elimination capacity after ETA blockade. Conclusion: ET-1 induced reduction in insulin sensitivity and clearance as well as splanchnic and renal vasoconstriction are ETA mediated. ETA receptor stimulation seems to inhibit the conversion of big ET-1 to ET-1.




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
G. Ahlborg, A. Shemyakin, F. Bohm, A. Gonon, and J. Pernow
Dual Endothelin Receptor Blockade Acutely Improves Insulin Sensitivity in Obese Patients With Insulin Resistance and Coronary Artery Disease
Diabetes Care, March 1, 2007; 30(3): 591 - 596.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Lteif, P. Vaishnava, A. D. Baron, and K. J. Mather
Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans
Diabetes, March 1, 2007; 56(3): 728 - 734.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1966 by the American Physiological Society.